TGF-β Biology in mammary development and breast cancer

Cold Spring Harbor Perspectives in Biology

Volumn 3, Issue 1, 2011, Pages 1-14

  Moses, Harold ^a   Barcellos Hoff, Mary Helen ^b  

^a VANDERBILT INGRAM CANCER CENTER   (United States)

^b NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMALIA;

TRANSFORMING GROWTH FACTOR BETA1;

ANIMAL; BREAST TUMOR; EPITHELIUM CELL; FEMALE; GROWTH, DEVELOPMENT AND AGING; HUMAN; MAMMARY GLAND; METABOLISM; MORPHOGENESIS; MOUSE; PHYSIOLOGY; REVIEW; SIGNAL TRANSDUCTION;

ANIMALS; BREAST NEOPLASMS; EPITHELIAL CELLS; FEMALE; HUMANS; MAMMARY GLANDS, HUMAN; MICE; MORPHOGENESIS; SIGNAL TRANSDUCTION; TRANSFORMING GROWTH FACTOR BETA1;

EID: 84863866563     PISSN: None     EISSN: 19430264     Source Type: Journal    
DOI: 10.1101/cshperspect.a003277     Document Type: Article

References (110)

1. Abe M, Oda N, Sato Y. 1998. Cell-associated activation of latent transforming growth factor-β by calpain. J Cell Physiol 174: 186-193.
2. Akita K, Okuno M, Enya M, Imai S, Moriwaki H, Kawada N, Suzuki Y, Kojima S. 2002. Impaired liver regeneration in mice by lipopolysaccharide via TNF-[α]/kallikreinmediated activation of latent TGF-[β]. Gastroenterology 123: 352-364.
3. Andarawewa KL, Paupert J, Pal A, Barcellos-Hoff MH. 2007. New rationales for using TGFb inhibitors in radiotherapy. Int J Radiat Biol 83: 803-811.
4. Anscher MS, Peters WP, Reisenbichler H, Petros WP, Jirtle RL. 1993. Transforming growth factor b as a predictor of liver and lung fibrosis after autologous bone marrow transplantation for advanced breast cancer. New England J Med 328: 1592-1598.
5. Barcellos-Hoff MH, Dix TA. 1996. Redox-mediated activation of latent transforming growth factor-β1. Molec Endocrin 10: 1077-1083.
6. Barcellos-Hoff MH, Ehrhart EJ, Kalia M, Jirtle R, Flanders K, Tsang M.L.-S. 1995. Immunohistochemical detection of active TGF-b in situ using engineered tissue. Am J Pathol 147: 1228-1237.
7. Bhowmick NA, Chytil A, Plieth D, Gorska AE, Dumont N, Shappell S, Washington MK, Neilson EG, Moses HL. 2004. TGF-{β} signaling in fibroblasts modulates the oncogenic potential of adjacent epithelia. Science 303: 848-851.
8. Bierie B, Moses HL. 2009. Gain or loss of TGF-β signaling in mammary carcinoma cells can promote metastasis. Cell Cycle 8: 3319-3327.
9. Bierie B, Chung CH, Stover DG, Cheng N, Parker J, Chytil A, Aakre M, Shyr Y, Moses HL. 2009. Abrogation of TGF-ß signaling enhances chemokine production and correlates with prognosis in human breast cancer. J Clin Invest 119.
10. Bierie B, Gorska AE, Stover DG, Moses HL. 2009. TGF-β promotes cell death and suppresses lactation during the second stage of mammary involution. J Cell Physiol 219: 57-68.
11. Bierie B, Stover DG, Abel TW, Chytil A, Gorska AE, Aakre M, Forrester E, Yang L, Wagner K-U, Moses HL. 2008. Transforming growth factor-{β} regulates mammary carcinoma cell survival and interaction with the adjacent microenvironment. Cancer Res 68: 1809-1819.
12. Bottinger EP, Jakubczak JL, Haines DC, Bagnall K, Wakefield LM. 1997. Transgenic mice overexpressing a dominantnegative mutant type II transforming growth factor b receptor show enhanced tumorigenesis in the mammary gland and lung in response to the carcinogen 7,12-dimthylbenz-[a]-anthracene. Cancer Res 57: 5564-5570.
13. Boulanger CA, Smith GH. 2001. Reducing mammary cancer risk through premature stem cell senescence. Oncogene 20: 2264-2272.
14. Bresciani F. 1968. Topography ofDNA synthesis in the mammary gland of the C3H mouse and its control by ovarian hormones: An autoradiographic study. Cell Tiss Kinet 1: 51-63.
15. Brisken C, Park S, Vass T, Lydon JP, O'Malley BW, Weinberg RA. 1998. A paracrine role for the epithelial progesterone receptor in mammary gland development. Proc Natl Acad Sci 95: 5076-5081.
16. Brown KA, Pietenpol JA, Moses HL. 2007. A tale of two proteins: Differential roles and regulation of Smad2 and Smad3 in TGF-β signaling. J Cell Biochem 101: 9-33.
17. Brunner AM, Marquardt H, Malacko AR, Lioubin MN, Purchio AF. 1989. Site-directed mutagenesis of cysteine residues in the pro region of the transforming growth factor b 1 precursor. J Biol Chem 264: 13660-13664.
18. Butta A, MacLennan K, Flanders KC, Sacks NPM, Smith I, McKinna A, Dowsett M, Wakefield LM, Sporn MB, Baum M, et al. 1992. Induction of transforming growth factor β1 in human breast cancer in vivo following tamoxifen treatment. Cancer Res 52: 4261-4264.
19. Cheng N, Bhowmick NA, Chytil A, Gorksa AE, Brown KA, Muraoka R, Arteaga CL, Neilson EG, Hayward SW, Moses HL. 2005. Loss of TGF-[β] type II receptor in fibroblasts promotes mammary carcinoma growth and invasion through upregulation of TGF-[α]-, MSPand HGF-mediated signaling networks. Oncogene 24: 5053-5068.
20. Christov K, Swanson SM, Guzman RC, Thordarson G, Jin E, Talamantes F, Nandi S. 1993. Kinetics of mammary epithelial cell proliferation in pituitary isografted BALB/c mice. Carcinogenesis 14: 2019-2025.
21. Clarke RB, Howell A, Potten CS, Anderson E. 1997. Dissociation between steroid receptor expression and cell proliferation in the human breast. Cancer Res 57: 4987-4991.
22. Daly AC, Randall RA, Hill CS. 2008. Transforming growth factor {β}-induced Smad1/5 phosphorylation in epithelial cells is mediated by novel receptor complexes and is essential for anchorage-independent growth. Mol Cell Biol 28: 6889-6902.
23. Daniel CW, Robinson SD. 1992. Regulation of mammary growth and function by TGF-b. Mol Reprod Dev 32: 145-151.
24. Daniel CW, Silberstein GB, Strickland P. 1987. Direct action of 17 β-estradiol on mouse mammary ducts analyzed by sustained release implants and steroid autoradiography. Cancer Res 47: 6052-6057.
25. Daniel CW, Silberstein GB, Van Horn K, Strickland P, Robinson S. 1989. TGF-b1-induced inhibition of mouse mammary ductal growth: Developmental specificity and characterization. Develop Biol 135: 20-30.
26. Derynck R, Zhang YE. 2003. Smad-dependent and Smad-independent pathways in TGF-βfamily signalling. Nature 425: 577-584.
27. Ebisawa T, Fukuchi M, Murakami G, Chiba T, Tanaka K, Imamura T, Miyazono K. 2001. Smurf1 interacts with transforming growth factor-β type I receptor through Smad7 and induces receptor degradation. J Biol Chem 276: 12477-12480.
28. Ehrhart EJ, Carroll A, Segarini P, Tsang M.L.-S, Barcellos-Hoff MH. 1997. Latent transforming growth factor-b activation in situ: Quantitative and functional evidence following low dose irradiation. FASEB J 11: 991-1002.
29. Esserman L, Shieh Y, Thompson I. 2009. Rethinking screening for breast cancer and prostate cancer. JAMA 302: 1685-1692.
30. Ewan KBR, Oketch-Rabah HA, Ravani SA, Shyamala G, Moses HL, Barcellos-Hoff MH. 2005. Proliferation of estrogen receptor-α-positive mammary epithelial cells is restrained by transforming growth factor-β 1 in adult mice. Am J Pathol 167: 409-417.
31. Ewan KB, Shyamala G, Ravani SA, Tang Y, Akhurst RJ, Wakefield L, Barcellos-Hoff MH. 2002. Latent TGF-b activation in mammary gland: Regulation by ovarian hormones affects ductal and alveolar proliferation. Am J Path 160: 2081-2093.
32. Feng XH, Derynck R. 2005. Specificity and versatility in tgfbeta signaling through Smads. Annu Rev Cell Dev Biol 21: 659-693.
33. Feng Z, Jin S, Zupnick A, Hoh J, de Stanchina E, Lowe S, Prives C, Levine AJ. 2006. p53 tumor suppressor protein regulates the levels of huntingtin gene expression. Oncogene 25: 1-7.
34. Ferguson JE, Schor AM, Howell A, Ferguson MW. 1992. Changes in the extracellular matrix of the normal human breast during the menstrual cycle. Cell Tissue Res 268: 167-177.
35. Flaumenhaft R, Rifkin DB. 1992. The extracellular regulation of growth factor action. Mol Biol Cell 3: 1057-1065.
36. Forrester E, Chytil A, Bierie B, Aakre M, Gorska AE, Sharif-Afshar AR, Muller WJ, Moses HL. 2005. Effect of conditional knockout of the type II TGF-β receptor gene in mammary epithelia on mammary gland development and polyomavirus middle Tantigen induced tumor formation and metastasis. Cancer Res 65: 2296-2302.
37. Fynan TM, Reiss M. 1993. Resistance to inhibition of cell growth by transforming growth factor-b and its role in oncogenesis. Critical Rev Oncogen 4: 493-540.
38. Ge R, Rajeev V, Ray P, Lattime E, Rittling S, Medicherla S, Protter A, Murphy A, Chakravarty J, Dugar S, et al. 2006. Inhibition of growth and metastasis of mouse mammary carcinoma by selective inhibitor of transforming growth factor-β type I receptor kinase in vivo. Clin Cancer Res 12: 4315-4330.
39. Gomis RR, Alarcón C, He W, Wang Q, Seoane J, Lash A, Massagué J. 2006. A FoxO-Smad synexpression group in human keratinocytes. Proc Nat Acad Sci 103: 12747-12752.
40. Gomm JJ, Smithe J, Ryall GK, Baillie R, Turnbull L, Coombes RC. 1991. Localization of basic fibroblast growth factor and transforming growth factor β1 in the human mammary gland. Cancer Res 51: 4685-4692.
41. Gorska AE, Jensen RA, Shyr Y, Aakre ME, Bhowmick NA, Moses HL. 2003. Transgenic mice expressing a dominantnegative mutant type II transforming growth factor-β receptor exhibit impaired mammary development and enhanced mammary tumor formation. Am J Pathol 163: 1539-1549.
42. Hayashi H, Abdollah S, Qiu Y, Cai J, Xu YY, Grinnell BW, Richardson MA, Topper JN, Gimbrone MA Jr, Wrana JL, et al. 1997. The MAD-related protein Smad7 associates with the TGF-β receptor and functions as an antagonist of TGF-β signaling. Cell 89: 1165-1173.
43. Hinshelwood RA, Huschtscha LI, Melki J, Stirzaker C, Abdipranoto A, Vissel B, Ravasi T, Wells CA, Hume DA, Reddel RR, et al. 2007. Concordant epigenetic silencing of transforming growth factor-signaling pathway genes occurs early in breast carcinogenesis. Cancer Res 67: 11517-11527.
44. Humphreys RC, Krajewska M, Krnacik S, Jaeger R, Weiher H, Krajewski S, Reed JC, Rosen JM. 1996. Apoptosis in the terminal endbud of the murine mammary gland: A mechanism of ductal morphogenesis. Development 122: 4013-4022.
45. Inoue Y, Imamura T. 2008. Regulation of TGF-β family signaling by E3 ubiquitin ligases. Cancer Sci 99: 2107-2112.
46. Jhappan C, Geiser AG, Kordon EC, Bagheri D, Hennighausen L, Roberts AB, Smith GH, Merlino G. 1993. Targeting expression of a transforming growth factor β1 transgene to the pregnant mammary gland inhibits alveolar development and lactation. EMBO J 12: 1835-1845.
47. Jobling MF, Mott JD, Finnegan M, Erickson AC, Taylor SE, Ledbetter S, Barcellos-Hoff MH. 2006. Isoform specificity of redox-mediated TGF-b activation. Radiat Res 166: 839-848.
48. Joseph H, Gorska AE, Sohn P, Moses HL, Serra R. 1999. Overexpression of a kinase-deficient transforming growth factor-b type II receptor in mouse mammary stroma results in increased epithelial branching. Molec Biol Cell 10: 1221-1234.
49. Kang SH, Bang YJ, Im YH, Yang HK, Lee DA, Lee HY, Lee HS, Kim NK, Kim SJ. 1999. Transcriptional repression of the transforming growth factor-β type I receptor gene by DNA methylation results in the development of TGF-β resistance in human gastric cancer. Oncogene 18: 7280-7286.
50. Kavsak P, Rasmussen RK, Causing CG, Bonni S, Zhu H, Thomsen GH, Wrana JL. 2000. Smad7 binds to Smurf2 to form an E3 ubiquitin ligase that targets the TGF[β] receptor for degradation. Mol Cell 6: 1365-1375.
51. Kim SJ, Angel P, Lafyatis R, Hattori K, Kim KY, Sporn MB, Karin M, Roberts AB. 1990. Autoinduction of transforming growth factor β1 is mediated by the AP-1 complex. Mol Cell Biol 10: 1492-1497.
52. Kim SJ, Im YH, Markowitz SD, Bang YJ. 2000. Molecular mechanisms of inactivation of TGF-β receptors during carcinogenesis. Cytokine Growth Factor Rev 11: 159-168.
53. Kim S-J, Park K, Koeller D, Kim KY, Wakefield LM, Sporn MB, Roberts AB. 1992. Post-transcriptional regulation of the human transforming growth factor-β1 gene. J Biol Chem 267: 13702-13707.
54. Knabbe C, Lippman ME, Wakefield LM, Flanders KC, Dasid A, Derynck R, Dickson RB. 1987. Evidence that transforming growth factor-b is a hormonally regulated negative growth factor in human breast cancer cells. Cell 48: 417-428.
55. Kordon EC, McKnight RA, Jhappan C, Hennighausen L, Merlino G, Smith GH. 1995. Ectopic TGF β 1 expression in the secretory mammary epithelium induces early senescence of the epithelial stem cell population. Dev Biol 168: 47-61.
56. Kuperwasser C, Chavarria T, Wu M, Magrane G, Gray JW, Carey L, Richardson A, Weinberg RA. 2004. From the cover: Reconstruction of functionally normal and malignant human breast tissues inmice. PNAS 101: 4966-4971.
57. Lee MK, Pardoux C, Hall MC, Lee PS, Warburton D, Qing J, Smith SM, Derynck R. 2007. TGF-β activates Erk MAP kinase signalling through direct phosphorylation of ShcA. EMBO J 26: 3957-3967.
58. Levy L, Hill CS. 2006. Alterations in components of the TGF-β superfamily signaling pathways in human cancer. Cytokine Growth Factor Rev 17: 41-58.
59. Lippman ME, Dickson RB, Gelmann EP. 1988. Human breast carcinoma cells produce growth regulatory peptides. Progress Cancer Res Therapy 35: 263-269.
60. Liu IM, Schilling SH, Knouse KA, Choy L, Derynck R, Wang X-F. 2009. TGF[β]-stimulated Smad1/5 phosphorylation requires the ALK5 L45 loop and mediates the pro-migratory TGF[β] switch. EMBO J 28: 88-98.
61. Luo K, Stroschein SL, Wang W, Chen D, Martens E, Zhou S, Zhou Q. 1999. The Ski oncoprotein interacts with the Smad proteins to repress TGF-β signaling. Genes Dev 13: 2196-2206.
62. Lydon JP, DeMayo FJ, Funk CR, Mani SK, Hughes AR, Montgomery CA Jr, Shyamala G, Conneely OM, O'Malley BW. 1995. Mice lacking progesterone receptor exhibit pleiotropic reproductive abnormalities. Genes Dev 9: 2266-2278.
63. Lyons RM, Keski-Oja J, Moses HL. 1988. Proteolytic activation of latent transforming growth factor-b from fibroblast conditioned medium. J Cell Biol 106: 1659-1665.
64. Martikainen P, Kyprianou N, Isaacs JT. 1990. Effect of transforming growth factor-β1 on proliferation and death of rat prostatic cells. Endocrinology 127: 2963-2968.
65. Massagué J. 2008. TGF[β] in Cancer. Cell 134: 215-230.
66. Massague J, Seoane J, Wotton D. 2005. Smad transcription factors. Genes Dev 19: 2783-2810.
67. Maxwell CA, Fleisch MC, Costes SV, Erickson AC, Boissiere A, Gupta R, Ravani SA, Parvin B, Barcellos-Hoff MH. 2008. Targeted and nontargeted effects of ionizing radiation that impact genomic instability. Cancer Res 68: 8304-8311.
68. Miyazono K, Heldin C-H. 1989. Role for carbohydrate structures in TGF-b1 latency. Nature 338: 158-160.
69. Moses HL, Roberts AB. 2008. The discovery of TGF-ß: A historical perspective. In The TGF-ß family (ed. K.R.A.M. Derynck), pp. 1-28. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
70. Moustakas A, Heldin CH. 2007. Signaling networks guiding epithelial-mesenchymal transitions during embryogenesis and cancer progression. Cancer Sci 98: 1512-1520.
71. Munger J, Huang X, Kawakatsu H, Griffiths M, Dalton S, Wu J, Pittet J, Kaminski N, Garat C, Matthay M, et al. 1999. The integrin α v β 6 binds and activates latent TGF β 1: A mechanism for regulating pulmonary inflammation and fibrosis. Cell 96: 319-328.
72. Muraoka-Cook RS, Kurokawa H, Koh Y, Forbes JT, Roebuck LR, Barcellos-Hoff MH, Moody SE, Chodosh LA, Arteaga CL. 2004. Conditional overexpression of active transforming growth factor b accelerates metastases of transgenic mammary tumors. Cancer Res 64: 9002-9011.
73. Muraoka-Cook RS, Shin I, Yi JY, Easterly E, Barcellos-Hoff MH, Yingling JM, Zent R, Arteaga CL. 2005. Activated type I TGF[β] receptor kinase enhances the survival of mammary epithelial cells and accelerates tumor progression. Oncogene doi: 10.1038/sj.onc.1208964:1-16.
74. Nakao A, Afrakhte M, Moren A, Nakayama T, Christian JL, Heuchel R, Itoh S, Kawabata M, Heldin NE, Heldin CH, et al. 1997. Identification of Smad7, a TGF-β-inducible antagonist of TGF-β signalling. Nature 389: 631-635.
75. Nelson CM, VanDuijn MM, Inman JL, Fletcher DA, Bissell MJ. 2006. Tissue geometry determines sites of mammary branching morphogenesis in organotypic cultures. Science 314: 298-300.
76. Newton LK, Yung WKA, Pettigrew LC, Steck PA. 1990. Growth regulatory activities of endothelial extracellular matrix mediation by transforming growth factor-b. Expt Cell Res 190: 127-132.
77. Nguyen AV, Pollard JW. 2000. Transforming growth factor b3 induces cell death during the first stage of mammary gland involution. Development 127: 3107-3118.
78. Padua D, Zhang XHF, Wang Q, Nadal C, Gerald WL, Gomis RR, Massagué J. 2008. TGF[β] primes breast tumors for lung metastasis seeding through angiopoietin-like 4. Cell 133: 66-77.
79. Parekh TV, Gama P, Wen X, Demopoulos R, Munger JS, Carcangiu M-L, Reiss M, Gold LI. 2002. Transforming growth factor {β} signaling is disabled early in human endometrial carcinogenesis concomitant with loss of growth inhibition. Cancer Res 62: 2778-2790.
80. Pertovaara L, Sistonen L, Bos TJ, Vogt PK, Keski OJ, Alitalo K. 1989. Enhanced jun gene expression is an early genomic response to transforming growth factor β stimulation. Mol Cell Biol 9: 1255-1262.
81. Pierce DF, Gorska AE, Chythil A, Meise KS, Page DL, Coffey RJ Jr, Moses HL. 1995. Mammary tumor suppression by transforming growth factor β1 transgene expression. Proc Natl Acad Sci 92: 4254-4258.
82. Pierce DFJ, Johnson MD, Matsui Y, Robinson SD, Gold LI, Purchio AF, Daniel CW, Hogan BLM, Moses HL. 1993. Inhibition of mammary duct development but not alveolar outgrowth during pregnancy in transgenic mice expressing active TGF-b 1. Genes Dev 7: 2308-2317.
83. Roberts AB, Sporn MB, Assoian RK, Smithe JM, Roche NS, Wakefield LM, Heine UI, Liotta LA, Falanga V, Kehrl JH, et al. 1986. Transforming growth factor type b: Rapid induction of fibrosis and angiogenesis in vivo and stimulation of collagen formation in vitro. Proc Natl Acad Sci 83: 4167-4171.
84. Robinson SD, Roberts AB, Daniel CW. 1993. TGFb suppresses casein synthesis in mouse mammary explants and may play a role in controlling milk levels. J Cell Biol 120: 245-251.
85. Rotello RJ, Lieberman RC, Purchio AF, Gerschenson LE. 1991. Coordinated regulation of apoptosis and cell proliferation by transforming growth factor b 1 in cultured uterine epithelial cells. Proc Natl Acad Sci 88: 3412-3415.
86. Schultz-Cherry S, Hinshaw V. 1996. Influenza virus neuraminidase activates latent transforming growth factor beta. J Virol 70: 8624-8629.
87. Schultz-Cherry S, Murphy-Ullrich JE. 1993. Thrombospondin causes activation of latent transforming growth factor-b secreted by endothelial cells by a novel mechanism. J Cell Biol 122: 923-932.
88. Shi Y, Massague J. 2003. Mechanisms of TGF-beta signaling from cell membrane to the nucleus. Cell 113: 685-700.
89. Shipitsin M, Campbell LL, Argani P, Weremowicz S, Bloushtain-Qimron N, Yao J, Nikolskaya T, Serebryiskaya T, Beroukhim R, Hu M, et al. 2007. Molecular definition of breast tumor heterogeneity. Cancer Cell 11: 259-273.
90. Siegel PM, ShuW, Cardiff RD, Muller WJ, Massague J. 2003. Transforming growth factor β signaling impairs Neuinduced mammary tumorigenesis while promoting pulmonary metastasis. Proc Natl Acad Sci U S A 100: 8430-8435.
91. Silberstein GB, Daniel CW. 1987. Reversible inhibition of mammary gland growth by transforming growth factor-ß. Science 237: 291-293.
92. Silberstein GB, Flanders KC, Roberts AB, Daniel CW. 1992. Regulation of mammary morphogenesis: Evidence for extracellular matrix-mediated inhibition of ductal budding by transforming growth factor-β1. Dev Biol 152: 354-362.
93. Silberstein GB, Strickland P, Coleman S, Daniel CW. 1990. Epithelium-dependent extracellular matrix synthesis in transforming growth factor-β1-growth-inhibited mouse mammary gland. J Cell Biol 110: 2209-2219.
94. Simian M, Bissell M, Barcellos-Hoff M, Shyamala G. 2009. Estrogen and progesterone receptors have distinct roles in the establishment of the hyperplastic phenotype in PR-A transgenic mice. Breast Cancer Res 11: R72.
95. Soriano JV, Orci L, Montesano R. 1996. TGF-b1 induces morphogenesis of branching cords by cloned mammary epithelial cells at subpicomolar concentrations. Biochem Biophys Res Comm 220: 879-885.
96. Stampfer MR, Yaswen P, Alhadeff M, Hosoda J. 1993. TGF-b induction of extracellular matrix associated proteins in normal and transformed human mammary epithelial cells in culture is independent of growth effects. J Cell Physiol 155: 210-221.
97. Strange R, Li F, Saurer S, Burkhardt A, Friis RR. 1992. Apoptotic cell death and tissue remodeling during mouse mammary gland involution. Development (Camb) 115: 49-58.
98. Streuli CH, Schmidhauser C, Kobrin M, Bissell MJ, Derynck R. 1993. Extracellular matrix regulates expression of the TGF-b1 gene. J Cell Biol 120: 253-260.
99. Stroschein SL, Wang W, Zhou S, Zhou Q, Luo K. 1999. Negative feedback regulation of TGF-signaling by the SnoN Oncoprotein. Science 286: 771-774.
100. Taipale J, Lohi J, Saarinen J, Kovanen PT, Keski-Oja J. 1995. Human mast cell chymase and leukocyte elastase release latent transforming growth factor-1 from the extracellular matrix of cultured human epithelial and endothelial cells. J Biol Chem 270: 4689-4696.
101. Tan AR, Alexe G, Reiss M. 2009. Transforming growth factor-β signaling: Emerging stem cell target in metastatic breast cancer? Breast Cancer Res Treat 115: 453-495.
102. Vijayachandra K, Higgins W, Lee J, Glick A. 2009. Induction of p16ink4a and p19ARF by TGF1 contributes to growth arrest and senescence response in mouse keratinocytes. Mol Carcinog 48: 181-186.
103. Wakefield l, Colletta AA, McCune BK, Sporn MB. 1991. Roles for transforming growth factors-b in the genesis, prevention and treatment of breast cancer. In Genes, oncogens, and hormones: Advances in cellular and molecular biology of breast cancer (ed. Dickson R.B. Lippman M.E.), pp. 97-136. Kluwer Academic Publishers, Boston.
104. Xie J, Haslam SZ. 1997. Extracellular matrix regulates ovarian hormone-dependent proliferation of mouse mammary epithelial cells. Endocrinology 138: 2466-2473.
105. Xie W, Mertens JC, Reiss DJ, Rimm DL, Camp RL, Haffty BG, Reiss M. 2002. Alterations of Smad signaling in human breast carcinoma are associated with poor outcome: Atissue microarray study. Cancer Res 62: 497-505.
106. Yamashita M, Fatyol K, Jin C, Wang X, Liu Z, Zhang YE. 2008. TRAF6 mediates Smad-independent activation of JNK and p38 by TGF-[β]. Molecular Cell 31: 918-924.
107. Yang Y-A, Dukhanina O, Tang B, Mamura M, Letterio JJ, MacGregor J, Patel SC, Khozin S, Liu Z-y, Green J, et al. 2002. Lifetime exposure to a soluble TGF-{β} antagonist protects mice against metastasis without adverse side effects. J Clin Invest 109: 1607-1615.
108. Yang L, Huang J, Ren X, Gorska AE, Chytil A, Aakre M, Carbone DP, Matrisian LM, Richmond A, et al. 2008. Abrogation of TGF[β] signaling in mammary carcinomas recruits Gr-1+CD11b+ myeloid cells that promote metastasis. Cancer Cell 13: 23-35.
109. Yingling JM, Blanchard KL, Sawyer JS. 2004. Development of TGF-β signalling inhibitors for cancer therapy. Nat Rev Drug Discov 3: 1011-1022.
110. Yu Q, Stamenkovic I. 2000. Cell surface-localized matrix metalloproteinase-9 proteolytically activates TGF-β and promotes tumor invasion and angiogenesis. Genes Dev 14: 163-176.